Pedro Marín Selected Research

Macrolides

12/2022	Pharmacokinetics of tildipirosin in horses after intravenous and intramuscular administration and its potential muscle damage.
5/2022	Quantification and Determination of Stability of Tylvalosin in Pig Plasma by Ultra-High Liquid Chromatography with Ultraviolet Detection.
4/2022	Pharmacokinetics of Tildipirosin in Plasma, Milk, and Somatic Cells Following Intravenous, Intramuscular, and Subcutaneous Administration in Dairy Goats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Marín Research Topics

Disease

6	Bacterial Infections (Bacterial Infection) 05/2022 - 06/2006
4	Crohn Disease (Crohn's Disease) 05/2024 - 01/2016
4	Multiple Myeloma 04/2021 - 09/2016
3	Lymphoma (Lymphomas) 04/2021 - 09/2016
2	Mastitis 01/2020 - 04/2011
2	Fever (Fevers) 01/2020 - 01/2020
1	Cardiotoxicity 12/2022
1	Inflammation (Inflammations) 12/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2022
1	Pneumonia (Pneumonitis) 02/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Mucositis 01/2016
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Body Weight (Weight, Body) 12/2009
1	Multiple Sclerosis 03/2003
1	Infections 07/2002
1	Residual Neoplasm 07/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2002
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2002

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2020
3	20,23- dipiperidinyl- mycaminosyl- tylonolideIBA 12/2022 - 08/2020
3	MacrolidesIBA 12/2022 - 04/2022
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2002
2	FluoroquinolonesIBA 02/2022 - 01/2020
2	plerixafor FDA Link 04/2021 - 09/2016
2	difloxacinIBA 04/2011 - 06/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024
1	TroponinIBA 12/2022
1	MB Form Creatine KinaseIBA 12/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2022
1	HaptoglobinsIBA 12/2022
1	tylvalosinIBA 05/2022
1	delafloxacinIBA 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	Cefonicid (Monocid)FDA Link 01/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018
1	AnthracyclinesIBA 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	pomalidomideIBA 01/2018
1	NucleosidesIBA 01/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 11/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	EnrofloxacinIBA 12/2009
1	danofloxacinIBA 12/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2002

Therapy/Procedure

8	Stem Cell Transplantation 05/2024 - 01/2002
4	Therapeutics 01/2019 - 03/2003
2	Patient Readmission 01/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2018 - 09/2016
2	Transplantation 09/2016 - 07/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2003 - 07/2002
1	Antibiotic Prophylaxis 01/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Photopheresis 01/2019